Miller SD - Search Results

1

Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE.

Vanderlugt CL, Karandikar NJ, Lenschow DJ, Dal Canto MC, Bluestone JA, Miller SD. Vanderlugt CL, et al. Among authors: miller sd. J Neuroimmunol. 1997 Nov;79(2):113-8. doi: 10.1016/s0165-5728(97)00108-2. J Neuroimmunol. 1997. PMID: 9394783

2

Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis.

Miller SD, Tan LJ, Pope L, McRae BL, Karpus WJ. Miller SD, et al. Int Rev Immunol. 1992;9(3):203-22. doi: 10.3109/08830189209061791. Int Rev Immunol. 1992. PMID: 1285061 Review.

3

Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats.

Pope L, Paterson PY, Miller SD. Pope L, et al. Among authors: miller sd. J Neuroimmunol. 1992 Apr;37(3):177-89. doi: 10.1016/0165-5728(92)90002-3. J Neuroimmunol. 1992. PMID: 1373153

4

Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.

Tan LJ, Kennedy MK, Miller SD. Tan LJ, et al. Among authors: miller sd. J Immunol. 1992 May 1;148(9):2748-55. J Immunol. 1992. PMID: 1374098

5

Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein.

McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Picha KS, Miller SD. McRae BL, et al. Among authors: miller sd. J Neuroimmunol. 1992 Jun;38(3):229-40. doi: 10.1016/0165-5728(92)90016-e. J Neuroimmunol. 1992. PMID: 1376328

6

Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition.

Bluestone JA, Jameson S, Miller S, Dick R 2nd. Bluestone JA, et al. J Exp Med. 1992 Dec 1;176(6):1757-61. doi: 10.1084/jem.176.6.1757. J Exp Med. 1992. PMID: 1460430 Free PMC article.

7

Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination.

Miller SD, Gerety SJ, Kennedy MK, Peterson JD, Trotter JL, Tuohy VK, Waltenbaugh C, Dal Canto MC, Lipton HL. Miller SD, et al. J Neuroimmunol. 1990 Jan;26(1):9-23. doi: 10.1016/0165-5728(90)90115-4. J Neuroimmunol. 1990. PMID: 1688446 Free PMC article.

8

Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.

Kennedy MK, Tan LJ, Dal Canto MC, Tuohy VK, Lu ZJ, Trotter JL, Miller SD. Kennedy MK, et al. Among authors: miller sd. J Immunol. 1990 Feb 1;144(3):909-15. J Immunol. 1990. PMID: 1688591

9

Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance.

Tan LJ, Kennedy MK, Dal Canto MC, Miller SD. Tan LJ, et al. Among authors: miller sd. J Immunol. 1991 Sep 15;147(6):1797-802. J Immunol. 1991. PMID: 1716280

10

Specific immunoregulation of the induction and effector stages of relapsing EAE via neuroantigen-specific tolerance induction.

Miller SD, Tan LJ, Kennedy MK, Dal Canto MC. Miller SD, et al. Ann N Y Acad Sci. 1991 Dec 30;636:79-94. doi: 10.1111/j.1749-6632.1991.tb33440.x. Ann N Y Acad Sci. 1991. PMID: 1724364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

682 results

Search Page

Filters